Integra Lifesciences Holdings Corp (NASDAQ:IART) shares, rose in value, with the stock price up by 0.51% to the previous day’s close as strong demand from buyers drove the stock to $15.83.
Actively observing the price movement in the last trading, the stock closed the session at $15.75, falling within a range of $15.455 and $15.955. The value of beta (5-year monthly) was 1.245. Referring to stock’s 52-week performance, its high was $32.66, and the low was $15.51. On the whole, IART has fluctuated by -30.63% over the past month.
With the market capitalization of Integra Lifesciences Holdings Corp currently standing at about $1.22 billion, investors are eagerly awaiting this quarter’s results, scheduled for on 2025-Feb-24.
Projections by analysts suggest varying estimates for the company’s quarterly revenue. Analysts have estimated the company’s revenue for the quarter at 1.68B, with a low estimate of 379.29M and a high estimate of 385M. Wall Street analysts also predicted that the company’s y-o-y revenues would reach 381.17M.
Technical indicators serve as essential tools for traders, offering insights into market sentiment and potential price movements. We see that IART’s technical picture suggests that short-term indicators denote the stock is a 100% Sell on average. However, medium-term indicators have put the stock in the category of 100% Sell while long-term indicators on average have been pointing out that it is a 50% Sell.
The stock’s technical analysis shows that the price of IART currently trading nearly -19.54% and -27.40% away from the simple moving averages for 20 and 50 days respectively. The Relative Strength Index (RSI, 14) currently indicates a reading of 24.31, while the 7-day volatility ratio is showing 6.20% which for the 30-day chart, stands at 5.96%. Furthermore, Integra Lifesciences Holdings Corp (IART)’s beta value is 1.34, and its average true range (ATR) is 1.19.
A comparison of Integra Lifesciences Holdings Corp (IART) with its peers suggests the former has fared considerably weaker in the market. IART showed an intraday change of 0.51% in last session, and over the past year, it shrunk by -50.25%%.
Data on historical trading for Integra Lifesciences Holdings Corp (NASDAQ:IART) indicates that the trading volumes over the past 10 days have averaged 0.74 and over the past 3 months, they’ve averaged 689.42K. According to company’s latest data on outstanding shares, there are 77.17 million shares outstanding.
Nearly 14.38% of Integra Lifesciences Holdings Corp’s shares belong to company insiders and institutional investors own 92.67% of the company’s shares. The data on short interest also indicates that stock shorts accounted for 3.31 million shares as on 2025-03-31, resulting in a short ratio of 4.42. According to the data, the short interest in Integra Lifesciences Holdings Corp (IART) stood at 700.00 of shares outstanding as of 2025-03-31; the number of short shares registered in 2025-02-28 reached 3.91 million. The stock has fallen by -30.20% since the beginning of the year, thereby showing the potential of a further growth. This could raise investors’ confidence to be optimistic about the IART stock heading into the next quarter.
